ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

NRBO NeuroBo Pharmaceuticals Inc

3.73
0.05 (1.36%)
2024年5月3日 - 終了
15分遅延
名称 銘柄コード 市場 種別
NeuroBo Pharmaceuticals Inc NRBO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.05 1.36% 3.73 08:50:01
始値 安値 高値 終値 前日終値
3.67 3.55 3.73 3.73 3.68
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/3021:01PRNUSNeuroBo to Present Latest Pre-Clinical Data on..
2024/4/1721:05PRNUSNeuroBo Pharmaceuticals Doses First Patient in Its Phase 1..
2024/4/0121:01PRNUSNeuroBo Pharmaceuticals Completes Enrollment of Part 1 of..
2024/3/2821:01PRNUSNeuroBo Pharmaceuticals Reports Year End 2023 Financial..
2024/3/1321:01PRNUSNeuroBo Pharmaceuticals Receives Safety Review Committee..
2024/3/0422:01PRNUSNeuroBo Pharmaceuticals Appoints Seasoned Life Science..
2024/3/0421:30EDGAR2Form 8-K - Current report
2024/2/2922:30EDGAR2Form 8-K - Current report
2024/2/2922:01PRNUSNeuroBo Pharmaceuticals Receives First Site IRB Approval for..
2024/2/1422:52EDGAR2Form 8-K - Current report
2024/2/1222:01PRNUSNeuroBo Pharmaceuticals to Participate in the BIO CEO &..
2024/2/0122:30EDGAR2Form 8-K - Current report
2024/2/0122:01PRNUSNeuroBo Pharmaceuticals Announces FDA Clearance of IND for a..
2024/1/1822:30EDGAR2Form 8-K - Current report
2024/1/1822:01PRNUSNeuroBo Pharmaceuticals Reports Positive Pre-Clinical Safety..
2024/1/0922:45EDGAR2Form 8-K - Current report
2024/1/0922:30PRNUSNeuroBo Pharmaceuticals Regains Compliance with Nasdaq..
2024/1/0222:01PRNUSNeuroBo to Participate in Industry and Investor Conferences..
2023/12/2823:00EDGAR2Form 8-K - Current report
2023/12/2822:45PRNUSNeuroBo Pharmaceuticals Submits IND Application to the FDA..
2023/12/1923:03EDGAR2Form 8-K - Current report
2023/12/1922:43PRNUSNeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock..
2023/12/0723:20EDGAR2Form 8-K - Current report
2023/12/0122:31PRNUSNeuroBo to Participate in Investor Conferences in December
2023/11/1406:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1406:14EDGAR2Form 8-K - Current report
2023/11/1406:05PRNUSNeuroBo Pharmaceuticals Reports Third Quarter 2023 Financial..
2023/11/0622:20EDGAR2Form 8-K - Current report
2023/11/0622:05PRNUSNeuroBo Pharmaceuticals Strengthens Board of Directors with..
2023/10/3021:06EDGAR2Form 8-K - Current report
2023/10/1721:01PRNUSNeuroBo to Present at the H.C. Wainwright 7th Annual NASH..
2023/9/2221:03EDGAR2Form 8-K - Current report
2023/9/2005:15EDGAR2Form 8-K - Current report
2023/9/1521:11EDGAR2Form 8-K - Current report
2023/9/1521:01PRNUSNeuroBo Pharmaceuticals Doses First Patient in Its Phase 2a..
2023/8/2505:15EDGAR2Form 8-K - Current report
2023/8/1505:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1421:18EDGAR2Form 8-K - Current report
2023/8/1421:01PRNUSNEUROBO PHARMACEUTICALS APPOINTS HYUNG HEON KIM AS CHIEF..
2023/8/1005:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1005:20EDGAR2Form 8-K - Current report
2023/8/1005:05PRNUSNeuroBo Pharmaceuticals Reports Second Quarter 2023..
2023/8/0905:15EDGAR2Form 8-K - Current report
2023/8/0321:15EDGAR2Form 8-K - Current report
2023/8/0321:01PRNUSNeuroBo Pharmaceuticals Receives First Site IRB Approval for..
2023/8/0221:01PRNUSNeuroBo Pharmaceuticals Enters Into Term Sheet With MThera..
2023/7/2819:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2819:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2819:02EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
2023/6/2921:36EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock